EICHORCondition: Cardiovascular Disease · Coronary Artery Occlusion · Ischemic Heart Disease · Sponsor: Terumo Europe N.V.
The NAGOMI COMPLEX PMCF (Post-Market Clinical Follow-up) study has been designed to expand the knowledge about outcomes with the Ultimaster Nagomi™ sirolimus eluting coronary stent system (Ultimaster Nagomi™) in complex PCI subjects. The features for a complex PCI are based upon subgroup analysis of earlier published studies.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Klinikum Klagenfurt am Wörthersee | Klagenfurt, Austria | — |
| Imelda Hospital | Bonheiden, Belgium | — |
| C.H.U. Charleroi | Charleroi, Belgium | — |
| Ziekenhuis Oost-Limburg | Genk, Belgium | — |
| Hopital de Jolimont | La Louvière, Belgium | — |
| UZ Leuven | Leuven, Belgium | — |
| CHR Citadelle | Liège, Belgium | — |
| Clinique Saint-Luc Bouge | Namur, Belgium | — |
| CHU UCL Mont Godinne Namur | Yvoir, Belgium | — |
| East Tallinn Central Hospital | Tallinn, Estonia | — |
| CHU Jean Minjoz | Besançon, France | — |
| Hôpital Louis Pradel | Bron, France | — |
+ 40 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05705973